Each filer's latest filing for 500946108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Lynx1 Capital Management LP
13G/A
|
10.7% |
4/2/2026
Event 3/31/2026
|
||
| Lynx1 Capital Management LP | 10.7% | |||
| Weston Nichols | 10.7% | |||
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
|
9.9% |
11/16/2026
Event 9/30/2026
|
||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | |||
| VHCP Co-Investment Holdings III, LLC | 9.9% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | |||
| VHCP Management III, LLC | 9.9% | |||
| VHCP Management EG, LLC | 9.9% | |||
| Nimish Shah | 9.9% | |||
| Bong Y. Koh | 9.9% | |||
|
New Enterprise Associates 17, L.P.
13D/A
|
9.9% |
3/12/2026
Event 3/10/2026
|
||
| New Enterprise Associates 17, L.P. | 9.9% | |||
| NEA Partners 17, L.P. | 9.9% | |||
| Nea 17 GP, LLC | 9.9% | |||
| Forest Baskett | 9.9% | |||
| Ali Behbahani | 9.9% | |||
| Carmen Chang | 9.9% | |||
| Anthony A. Florence, Jr. | 9.9% | |||
| Mohamad H. Makhzoumi | 9.9% | |||
| Edward T. Mathers | 9.9% | |||
| Scott D. Sandell | 9.9% | |||
| Paul Walker | 9.9% | |||
| Rick Yang | 9.9% | |||
|
Adage Capital Management, L.P.
13G
|
6.8% |
11/12/2026
Event 9/30/2026
|
||
| Adage Capital Management, L.P. | 6.8% | |||
| Robert Atchinson | 6.8% | |||
| Phillip Gross | 6.8% | |||
|
Nantahala Capital Management, LLC
13G
|
6.4% |
2/13/2026
Event 12/31/2025
|
||
| Nantahala Capital Management, LLC | 6.4% | |||
| Wilmot B. Harkey | 6.4% | |||
| Daniel Mack | 6.4% | |||
|
Balyasny Asset Management L.P.
13G/A
|
5.9% |
11/16/2026
Event 9/30/2026
|
||
| Balyasny Asset Management L.P. | 5.9% | |||
| Bam GP LLC | 5.9% | |||
| Balyasny Asset Management Holdings LP | 5.9% | |||
| Dames GP LLC | 5.9% | |||
| Dmitry Balyasny | 5.9% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (9) | ||||
| BlackRock, Inc. 13G/A | 4.9% |
10/27/2026
Event 9/30/2026
|
||
|
Atlas Venture Fund XI, L.P.
13D/A
|
4.9% |
8/4/2026
Event 6/24/2026
|
||
| Atlas Venture Fund XI, L.P. | 4.9% | |||
| Atlas Venture Associates XI, L.P. | 4.9% | |||
| Atlas Venture Associates XI, LLC | 4.9% | |||
| Atlas Venture Opportunity Fund II, L.P. | 1.0% | |||
| Atlas Venture Associates Opportunity II, L.P. | 1.0% | |||
| Atlas Venture Associates Opportunity II, LLC | 1.0% | |||
|
Citadel Advisors LLC
13G/A
|
3.9% |
2/14/2025
Event 12/31/2024
|
||
| Citadel Advisors LLC | 3.9% | |||
| Citadel Advisors Holdings LP | 3.9% | |||
| Citadel GP LLC | 3.9% | |||
| Citadel Securities LLC | 0% | |||
| Citadel Securities Group LP | 0% | |||
| Citadel Securities GP LLC | 0% | |||
| Kenneth Griffin | 3.9% | |||
|
Deep Track Capital, LP
13G/A
|
3.0% |
8/14/2025
Event 6/30/2025
|
||
| Deep Track Capital, LP | 3.0% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 3.0% | |||
| David Kroin | 3.0% | |||
|
Point72 Asset Management, L.P.
13G/A
|
1.9% |
5/15/2026
Event 3/31/2026
|
||
| Point72 Asset Management, L.P. | 0% | |||
| Point72 Capital Advisors, Inc. | 0% | |||
| Point72 Biotech Private Investments, LLC | 1.9% | |||
| Differentiated Ventures Investments, LLC | 1.9% | |||
| 72 Investment Holdings, LLC | 1.9% | |||
| Steven A. Cohen | 1.9% | |||
|
FMR LLC
13G/A
|
0.4% |
2/5/2026
Event 12/31/2025
|
||
| FMR LLC | 0.4% | |||
| Abigail P. Johnson | 0.4% | |||
| AllianceBernstein L.P. 13G/A | 0.1% |
8/13/2025
Event 6/30/2025
|
||
| Driehaus Capital Management LLC 13G/A | 0% |
2/17/2026
Event 12/31/2025
|
||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 106 | 14.0 M | $139M |
| 2026 Q2 | 108 | 14.4 M | $190M |
| 2026 Q1 | 101 | 12.8 M | $145M |
| 2025 Q4 | 84 | 7.56 M | $60.6M |
| 2025 Q3 | 93 | 9.76 M | $466M |
| 2025 Q2 | 73 | 9.05 M | $115M |
| 2025 Q1 | 77 | 9.70 M | $169M |
| 2024 Q4 | 86 | 9.45 M | $360M |
| 2024 Q3 | 72 | 8.54 M | $285M |
| 2024 Q2 | 64 | 8.44 M | $286M |
| 2024 Q1 | 50 | 6.91 M | $619M |
| 2023 Q4 | 41 | 6.56 M | $302M |